Deutsche Bank Maintains Buy on Tenet Healthcare, Raises Price Target to $150
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $126 to $150.
May 30, 2024 | 5:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank has reaffirmed its Buy rating on Tenet Healthcare and increased the price target from $126 to $150, indicating strong confidence in the company's future performance.
The increase in the price target from $126 to $150 by Deutsche Bank suggests a positive outlook for Tenet Healthcare. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100